Pfizer

News

US regulator backs Pfizer's Vizimpro lung cancer drug

The US drug regulator has given Pfizer’s Vizimpro the green light in a group of lung cancer patients whose tumours have a certain mutation.

News

Pharma depriving developing countries of taxes - report

A damning report by Oxfam claims that pharma giants are ‘depriving’ developing countries of millions of dollars' worth of tax money annually.

News

Pfizer/Merck KGaA eye fast review for kidney cancer combo

A combination therapy based around Pfizer and Merck KGaA’s Bavencio has outperformed standard of care in a late-stage trial in untreated but advanced kidney cancer.

News

Allogene raises another $120m to develop 'off-the-shelf' CAR...

Startup biotech already raised $300m earlier this year

News

Pfizer axes development of Duchenne muscular dystrophy antib...

Pfizer has axed trials of its domagrozumab antibody for Duchenne muscular dystrophy (DMD), after it failed against efficacy targets.

News

Pfizer drug reduces mortality in patients with fatal heart d...

Pfizer’s heart disease drug, tafamidis, reduces mortality rates in patients, according to the top-line results of a phase 3 trial.

US regulator backs Pfizer's Vizimpro lung cancer drug

Pharma depriving developing countries of taxes - report

Pfizer/Merck KGaA eye fast review for kidney cancer combo

Allogene raises another $120m to develop 'off-the-shelf' CAR...

Pfizer axes development of Duchenne muscular dystrophy antib...

Pfizer drug reduces mortality in patients with fatal heart d...

Gilead strikes again, penning $5bn deal to buy Tubulis

Using AI-driven synthetic personas to take your insights fur...

Pfizer

Editor's Picks